Tci Gene (ROCO:6879) Marketable Securities: NT$581.0 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:6879 Tci Gene Inc ROCO:6879
60 GF Score
Price NT$34.00
GF Value NT$48.30
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is Tci Gene Marketable Securities?

Tci Gene ROCO:6879 60 Marketable Securities is NT$581.0 Mil as of Dec. 2025. GuruFocus rates ROCO:6879 with a GF Score™ of 60/100 and a GF Value™ of NT$48.30 (Possible Value Trap). The stock has 5 warning signs investors should review.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Tci Gene's Marketable Securities for the quarter that ended in Dec. 2025 was NT$581.0 Mil.

Tci Gene's annual Marketable Securities increased from Dec. 2023 (NT$203.6 Mil) to Dec. 2024 (NT$738.5 Mil) but then declined from Dec. 2024 (NT$738.5 Mil) to Dec. 2025 (NT$581.0 Mil).

Tci Gene  (ROCO:6879) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Tci Gene Marketable Securities Related Terms

Tci Gene Marketable Securities Historical Data

* Premium members only.

The historical data trend for Tci Gene's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Tci Gene Marketable Securities Chart

Tci Gene Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Marketable Securities
Get a 7-Day Free Trial 4.00 5.00 203.60 738.50 581.04

Tci Gene Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 203.60 749.25 738.50 616.83 581.04
ROCO:6879
60GF Score
Tci Gene Inc ROCO:6879
Marketable Securities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Tci Gene Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of NT$581.0 Mil mean?
Tci Gene (ROCO:6879) has a Marketable Securities of NT$581.0 Mil as of Dec. 2025. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Tci Gene and its competitors.
Is Tci Gene's Marketable Securities too high?
Tci Gene's current Marketable Securities is NT$581.0 Mil. Overall, Tci Gene has a GF Score™ of 60/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Tci Gene's Marketable Securities compare to VRTX and REGN?
Tci Gene's Marketable Securities of NT$581.0 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Biotechnology company?
A good Marketable Securities depends on the Biotechnology industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Tci Gene and its competitors. Tci Gene's current Marketable Securities is NT$581.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tci Gene stock overvalued right now?
Based on GuruFocus' analysis, Tci Gene (ROCO:6879) is currently considered Possible Value Trap. The stock's GF Value™ is NT$48.30, compared to a current price of NT$34.00 — trading 29.6% below its estimated fair value. The current Marketable Securities is NT$581.0 Mil. Tci Gene's overall GF Score™ is 60/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For Tci Gene (ROCO:6879), the current Marketable Securities is NT$581.0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Tci Gene (ROCO:6879) Overvalued in 2026?

Based on GuruFocus' analysis, Tci Gene stock appears to be undervalued. The current stock price of NT$34.00 is trading 29.6% below its estimated GF Value™ of NT$48.30. GuruFocus considers Tci Gene to be Possible Value Trap.

Key valuation signals for ROCO:6879:

  • Marketable Securities: NT$581.0 Mil
  • GF Value™: NT$48.30 vs. price of NT$34.00 (29.6% below fair value)
  • GF Score™: 60/100 with 5 warning signs

No single metric tells the full story. See the ROCO:6879 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Tci Gene Business Description

Address No. 185-1, Gangqian Road, 10th FLoor, Neihu District, Taipei, TWN
Tci Gene Inc provides precision preventive medicines in Taiwan. It is the first to introduce the concept of precision preventive medicine with Predict prediction, Prevent prevention, and Personal Treatment personalized health management measures.
60GF Score

Get the complete analysis for ROCO:6879

Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$34.00
Price
NT$48.30
GF Value